respiratory syncytial virus therapeutics (Pan Pacific)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namerespiratory syncytial virus therapeutics (Pan Pacific)
Drug Alias NamePX3.103RSV therapy (Pan Pacific)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPan Pacific Copper Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPan Pacific Copper Co Ltd
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A